Inland Private Capital, the Sponsor, reported that the Chicagoland Medical Portfolio DST sold its four freestanding medical office buildings on August 15, 2018. The buildings stood in Illinois and Massachusetts. The sponsor put the gross sale price at $45.7 million, as reported by the sponsor (REJournals).
On that sale the sponsor reported a 142.10% total return, as reported by the sponsor (GlobeSt), and a 10.76% average annualized return over the hold, as reported by the sponsor (GlobeSt). The announcement carried those two figures, not an equity multiple.
The Trust's first Form D, filed June 18, 2014, carried a $2 million offering amount and claimed a Rule 506(b) exemption (Form D). That $2 million is the amount on the initial notice, the only offering-amount figure the provided filing carries. Any later Form D amendments and the final equity the offering raised are not in the provided record, so the total raised cannot be known from these documents.
The sponsor reports the hold running from the June 2014 acquisition to the August 2018 sale, just over four years; the filing date and that acquisition date are distinct points. The portfolio's marketing title names Chicagoland, while the buildings the sponsor reported selling stood in both Illinois and Massachusetts.